Chemotherapy
出版商：S. Karger AG · ISSN：0009-3157, 1421-9794 · 国家/地区：CH · 类型：journal
核心指标
- 影响因子:1.400
- JCR 分区:Q4
- h-index:80
常见问题
《Chemotherapy》的影响因子是多少?
《Chemotherapy》的最新影响因子(IF)为 1.400。
《Chemotherapy》是几区期刊?
《Chemotherapy》JCR 分区为 Q4。
本刊近期代表论文
- Meta-Analysis of the Efficacy and Safety of Pembrolizumab in the Treatment of Advanced Gastric Cancer and Gastroesophageal Junction Cancer (2024 · 被引 5)
- Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma (2017 · 被引 2332)
- Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy (2016 · 被引 84)
- Biofilm Formation Restrained by Subinhibitory Concentrations of Tigecyclin in <b><i>Acinetobacter baumannii</i></b> Is Associated with Downregulation of Efflux Pumps (2016 · 被引 18)
- Phase II Trial of XELOX as First-Line Treatment for Patients with Advanced Gastric Cancer (2010 · 被引 49)
- Mechanisms and Influence of Octreotide-Induced Regulation of Somatostatin Receptor 2 on Hepatocellular Carcinoma (2009 · 被引 25)